Suzanne R Kalb

Title: Suzanne R Kalb: Innovator in Neurotoxin Detection

Introduction

Suzanne R Kalb is a prominent inventor based in Atlanta, GA (US). She has made significant contributions to the field of neurotoxin detection, particularly focusing on botulinum neurotoxins. With a total of 2 patents, her work has advanced the methods used for identifying and diagnosing these potent toxins.

Latest Patents

Kalb's latest patents include innovative methods for detecting botulinum neurotoxins. One of her notable inventions is titled "Peptide substrates recognizable by type E botulinum neurotoxin." This invention relates to peptide substrates that are selectively recognized by botulinum toxin type A and BoNT/E, which are crucial for detecting and diagnosing botulinum toxin type E. Another significant patent is "Mass spectrometry-based methods for detection and differentiation of botulinum neurotoxins." This method involves mixing a sample with a peptide substrate for proteolytic activity of clostridial neurotoxins and measuring the activity using mass spectroscopy techniques.

Career Highlights

Throughout her career, Kalb has worked with esteemed organizations such as Los Alamos National Security, LLC and the United States Department of Health and Human Services. Her experience in these institutions has allowed her to develop and refine her innovative approaches to neurotoxin detection.

Collaborations

Kalb has collaborated with notable professionals in her field, including John R Barr and Jurgen G Schmidt. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Suzanne R Kalb's contributions to the field of neurotoxin detection exemplify her innovative spirit and dedication to advancing scientific knowledge. Her patents reflect her commitment to improving methods for identifying harmful toxins, making a significant impact in public health and safety.